Mankind Pharma Q2 Profit Jumps 39% to Rs 712 Crore
Mankind Pharma reported net profit of Rs 712 crore for the September quarter, up 39% year on year. Its board also approved the merger of wholly owned subsidiaries Prolijune Lifesciences and Pavi Buildwell.